comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 03:32:08 - browse：425

Pascal Soriot 2019 — Pascal Soriot has served as CEO of AstraZeneca since 2012. Win McNamee/Getty Images

CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030.

Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs. It would also require outpacing the targets laid out by AstraZeneca’s large pharma peers.

But at an investor day here at the company’s shiny new Discovery Centre, CEO Pascal Soriot opened his presentation by bringing up the goal set by the company a decade ago — $45 billion in revenue by 2023. The company faced some declines early in that period, but after surging in the past few years, it hit that target, bringing in $45.8 billion last year. Its recent growth has also propelled the company’s share price.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

WSS

Pentagon will tighten controls on classified information after Discord leak

EU moves toward latest gene techniques in food production to counter climate change, shortages

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

5 shark bites reported on Long Island as officials deploy surveillance drones

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Oak Street deal isn't the answer to health care's woes

Peter Hotez and the public health issue of online harassment

Former New York Mayor de Blasio and wife announce separation, but not divorce

Virginia high school admissions case could be legal follow

Following judge's order, DOJ releases slightly less

The cancer drug shortage isn’t new — and neither are the solutions

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

entertainment

HHS suspends federal funding for EcoHealth Alliance

Cherokee Nation medical school graduates its first class

Princess Kate attends Wimbledon with Roger Federer: See the photos

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Boston hospital trains restaurant workers on naloxone for overdoses

A bus careens into a gulch in southern Mexico, leaving 27 people dead

focus

hotspot

hotspot

focus